Single- and multi-site pacing strategies for optimal cardiac resynchronization therapy: impact on device longevity and therapy cost
暂无分享,去创建一个
M. Bertini | G. Licciardello | L. Cipolletta | S. Valsecchi | G. Forleo | L. Santini | D. Ricciardi | P. Notarstefano | A. D'onofrio | M. Manzo | G. Savarese | M. Campari | T. Infusino | G. D'Arienzo | V. Bianchi | G. Russo | Francesca Fabbri | A. D’Onofrio
[1] R. Verlato,et al. The interventricular conduction time is associated with response to cardiac resynchronization therapy: interventricular electrical delay. , 2013, International journal of cardiology.
[2] Christophe Leclercq,et al. A review of multisite pacing to achieve cardiac resynchronization therapy. , 2015, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[3] D. Exner,et al. Relationship between left ventricular lead position using a simple radiographic classification scheme and long-term outcome with resynchronization therapy , 2008, Journal of Interventional Cardiac Electrophysiology.
[4] F. Gadler,et al. Economic impact of longer battery life of cardiac resynchronization therapy defibrillators in Sweden , 2016, ClinicoEconomics and outcomes research : CEOR.
[5] A. Natale,et al. Hospitalization rates and associated cost analysis of cardiac resynchronization therapy with an implantable defibrillator and quadripolar vs. bipolar left ventricular leads: a comparative effectiveness study , 2014, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[6] P. Khairy,et al. Acute haemodynamic comparison of multisite and biventricular pacing with a quadripolar left ventricular lead. , 2013, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[7] L. Di Biase,et al. Multipoint pacing via a quadripolar left-ventricular lead: preliminary results from the Italian registry on multipoint left-ventricular pacing in cardiac resynchronization therapy (IRON-MPP) , 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[8] J. Healey,et al. Left ventricular lead position and outcomes in the Resynchronization-Defibrillation for Ambulatory Heart Failure Trial (RAFT). , 2014, Canadian Journal of Cardiology.
[9] G. Boriani,et al. Impact of extending device longevity on the long-term costs of implantable cardioverter-defibrillator therapy: a modelling study with a 15-year time horizon. , 2013, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[11] Nigel Gupta,et al. Performance of Anatomically Designed Quadripolar Left Ventricular Leads: Results from the NAVIGATE X4 Clinical Trial , 2016, Journal of cardiovascular electrophysiology.
[12] R. Hauser,et al. The growing mismatch between patient longevity and the service life of implantable cardioverter-defibrillators. , 2005, Journal of the American College of Cardiology.
[13] F. Cuoco,et al. The relationship between ventricular electrical delay and left ventricular remodelling with cardiac resynchronization therapy , 2012 .
[14] A. Rapacciuolo,et al. Interlead anatomic and electrical distance predict outcome in CRT patients. , 2015, Heart rhythm.
[15] Lluís Mont,et al. 2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). , 2013, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[16] Wilfried Mullens,et al. Insights from a cardiac resynchronization optimization clinic as part of a heart failure disease management program. , 2009, Journal of the American College of Cardiology.
[17] M. A. Arias,et al. Estimation of the effects of multipoint pacing on battery longevity in routine clinical practice , 2017, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[18] F. Romeo,et al. Left ventricular pacing with a new quadripolar transvenous lead for CRT: early results of a prospective comparison with conventional implant outcomes. , 2011, Heart rhythm.
[19] Lluís Mont,et al. 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). , 2013, European heart journal.
[20] D. Theuns,et al. Longevity of implantable cardioverter defibrillators: a comparison among manufacturers and over time , 2015, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[21] A. Natale,et al. Improved implant and postoperative lead performance in CRT-D patients implanted with a quadripolar left ventricular lead. A 6-month follow-up analysis from a multicenter prospective comparative study , 2014, Journal of Interventional Cardiac Electrophysiology.
[22] A. Curnis,et al. The economic impact of battery longevity in implantable cardioverter-defibrillators for cardiac resynchronization therapy: the hospital and healthcare system perspectives , 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[23] A. Natale,et al. Clinical and procedural outcome of patients implanted with a quadripolar left ventricular lead: early results of a prospective multicenter study. , 2012, Heart rhythm.
[24] D. Mele,et al. Left Ventricular Lead Position Guided by Parametric Strain Echocardiography Improves Response to Cardiac Resynchronization Therapy , 2017, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[25] Wojciech Zareba,et al. Left Ventricular Lead Position and Clinical Outcome in the Multicenter Automatic Defibrillator Implantation Trial–Cardiac Resynchronization Therapy (MADIT-CRT) Trial , 2011, Circulation.
[26] Erwan Donal,et al. Sites of left and right ventricular lead implantation and response to cardiac resynchronization therapy observations from the REVERSE trial. , 2012, European heart journal.
[27] Giuseppe Boriani,et al. Battery drain in daily practice and medium-term projections on longevity of cardioverter-defibrillators: an analysis from a remote monitoring database , 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[28] D. Mele,et al. Cardiac resynchronization therapy guided by multimodality cardiac imaging , 2016, European journal of heart failure.
[29] Kenneth A. Ellenbogen,et al. The relationship between ventricular electrical delay and left ventricular remodelling with cardiac resynchronization therapy , 2011, European heart journal.
[30] J. Nielsen,et al. ESC Guidelines on cardiac pacing and cardiac resynchronization therapy , 2014 .
[31] G. Boriani,et al. Battery longevity of implantable cardioverter-defibrillators and cardiac resynchronization therapy defibrillators: technical, clinical and economic aspects. An expert review paper from EHRA , 2018, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[32] C. Morillo,et al. Left Ventricular Three‐Dimensional Quadripolar Lead Acute Clinical Study: The LILAC Study , 2015, Pacing and clinical electrophysiology : PACE.
[33] A. Curnis,et al. Longevity of implantable cardioverter-defibrillators for cardiac resynchronization therapy in current clinical practice: an analysis according to influencing factors, device generation, and manufacturer , 2015, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[34] G. Boriani,et al. Management of Phrenic Stimulation in CRT Patients over the Long Term: Still an Unmet Need ? , 2011, Pacing and clinical electrophysiology : PACE.
[35] L. Tavazzi,et al. Multipoint left ventricular pacing improves acute hemodynamic response assessed with pressure-volume loops in cardiac resynchronization therapy patients. , 2014, Heart rhythm.